The health system’s digital transformation arm, Mayo Clinic Platform, plans to use TripleBlind’s software to analyze patient data without seeing, sharing or storing it and test artificial intelligence models with Mayo’s Validate program while preserving intellectual property rights.
“Mayo Clinic Platform’s vision is to create a healthier world where personalized, predictive and innovative care may be accessible to all,” said Steve Bethke, vice president of Mayo Clinic Platform’s product portfolio, in a Jan. 31 TripleBlind news release. “We’re excited to collaborate with TripleBlind to enable solution developers to Validate their models, driving data-driven and scalable innovation in a secure environment.”
Mayo began investing in TripleBlind and using its application programming interface for digital health research in 2021.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
